Breaking News
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
Modeling Alzheimer’s Disease Using Microfluidics

Modeling Alzheimer’s Disease Using Microfluidics

image_pdfDownload PDFimage_print

An interview with Dr. Joseph Park, Ph.D., discussing the use of microfluidic systems in Alzheimer’s Disease research and the incorporation of microglia into the Alzheimer’s-in-a-dish culture system.

How are microfluidic systems used in research?

Microfluidic systems are tiny devices that have multiple chambers. They are used to mix small quantities of fluids and cells for interaction studies.

Microfluidics system - by science photoImage Credit: science photo / Shutterstock

In our research, we use microfluidic devices with two chambers; one contains neuron cells and astrocytes, and the other contains microglia. The two chambers are connected via migration channels.

When the neuronal cells and astrocytes become activated, they release chemicals that recruit microglia, which then move through the migration channels. Systems like this enable us to study the cell-cell interactions that can identify recruitment factors for the microglial cells.

What is the Alzheimer’s-in-a-dish culture system?

One of the most important things we are doing is culturing cells within 3D gels. This allows the cells to grow into a 3D tissue that is more representative of the human brain than cells grown in a 2D petri dish. We call this the Alzheimer’s-in-a-dish culture system.

As shown by our 2014 paper in Nature, we can entrap an Aβ peptide in this 3D gel and observe the Aβ plaque-like formation in the extracellular region. Furthermore, we were able to mimic the amyloid-beta (Aβ)-driven tau pathology including hyperphosphorylation (pTau) and neurofibrillary tangles (NFTs) which are the hallmarks of the late stage AD. This system will allow us to study and dissect the mechanism of neural-glial cells in a more physiologically-relevant environment.

Were there any drawbacks to the previous system?

The major limitation of this system was the lack of microglia. The human brain parenchyma contains four representative cell types; astrocytes, neurons, oligodendrocytes, and microglia cells, yet our system only contained the first three. This meant that the system we designed wasn’t a true representation of the brain, and any results we obtained weren’t as accurate as they could be.

Microglia are a type of immune cell that defend against pathogens and foreign bodies in the brain and CNS. They have a very important role in disease pathology because they clear dying neurons from the brain and remove toxins. In a balanced system, this works perfectly. However, the chronic activation of microglia results in inflammation and disease.

The role of microglia in Alzheimer’s disease is a controversial topic. Nobody knows whether they have a positive or negative effect, so it was important for us to design a microfluidic system that could incorporate these cells.

Neuronal connection - By Andrii VodolazhskyiImage Credit: Andrii Vodolazhskyi / Shutterstock

Please describe your recent study.

We took our original Alzheimer’s-in-a-dish culture system and added another chamber for microglial cells.

We found that if we cultured neuronal cells with Alzheimer’s disease-like environment (Aβ and NFTs) for more than nine weeks, they begin to secrete several cytokines including MCP1, TNF-α, and IFN-γ.

This cytokine is a potent recruitment signal for microglia, which become activated and damaged neuron/astrocyte inducing cellular death, which we think that may contribute to memory loss in humans.

CC: Central chamber, AC: Angular chamber, MC: Migration channel.

Why are the results of the study so ground-breaking for Alzheimer’s researchers?

Our system provides a new way to screen potential Alzheimer’s drugs. There are more than 3,000 approved compounds that could be used to target Alzheimer’s disease. You cannot screen all of these compounds in human models.

Using our system, scientists can screen molecules quickly in a model that accurately mimics Alzheimer’s disease in the human brain. If any of these compounds reduce microglial cell recruitment, we know that they will reduce neuronal damage.

What are the next steps for your research?

One of the drawbacks of the current system is that we used immortalized microglia cells. So, we are currently looking into ways of using normal and/or AD risk gene mutated microglial cells derived from induced pluripotent stem cells (iPSCs) that can give us a more physiologically relevant system to study microglia and/or glial activation in AD.

We also want to consider the potential of microglial cells as a treatment for Alzheimer’s disease. Let’s say we can use a drug that inhibits the side effects of microglial activation – the death of healthy neurons – and promotes the positive effects; i.e. the removal of amyloid plaques and dying neurons with tau tangles.

To do this, we are investigating whether induced-pluripotent stem cells (IPSCs) can be used to generate microglial cells that clear amyloid plaques.

Where can readers find more information?

About Dr. Joseph Park

My research aims at providing scientific solutions to the latest issues in the neurodegenerative disorder, particularly in Alzheimer’s disease (AD). AD is the leading cause of age-related neurodegenerative disease affecting over 5.2 million people in the United States.

While our knowledge underlying the AD pathogenic mechanism has greatly improved, no cure is available. Recent failures of anti-β-amyloid therapies in humans, which were highly effective in mouse models, might be explained the problematic issue of translating data from animals to human. Therefore, there is a pressing need to develop artificial human AD brain models to study molecular mechanisms for drug development.

My research is focused on (1) the development of in vitro human AD brain on a chip including iPSC-derived microglia, (2) proteomic profiling for the identification molecular pathways triggered by excess amyloid-beta in 3D AD neuron cells.

The aim is to constructively introduce a specific targeted brain area and enhance the physiologically relevant brain environment that conventional approaches cannot achieve.

Tagged with:

About author

Related Articles